Rising Australian Biotech Stars Set To Connect On The World Stage Two of Australia's leading life scientists have been chosen from a highly competitive field of candidates to take part in an initiative by Merck Sharp & Dohme and Advance to boost the capability of the country's burgeoning biopharmaceutical industry.
Source: www.medicalnewstoday.comStudy Shows Why Synthetic Estrogens Wreak Havoc On Reproductive System Researchers at Yale School of
Medicine now have a clearer understanding of why synthetic estrogens such as those found in many widely-used plastics have a detrimental effect on a developing fetus, cause fertility problems, as well as vaginal and breast cancers.Preliminary results of the study will be presented at the 2008 Society for Gynecologic Investigation (SGI) Annual Scientific Meeting held March 26-29 in San Diego, California. The study was led by Hugh S. Taylor, M.D.
Source: www.medicalnewstoday.comAntisense Therapeutics Scientist Out To Pull More Big Deals Aiming for more major licensing deals like the one his company recently secured with top 20 global pharmaceutical company, Teva, is front of mind for rising Australian biotechnology star, Antisense Therapeutics Ltd (ASX code: ANP)Research Director Dr Christopher Wraight when he meets with leading industry figures in the US in May.
Source: www.medicalnewstoday.comReflect Scientific, Inc. Receives U.S. Patent For Catalytic Inspection Method Reflect Scientific, Inc. (OTCBB: RSCF) announces that the Company has been issued another patent from the United States Patent Office. The patent discloses a unique method for inspecting an object having a planar face with surface variations. Management believes that the intellectual property contained within the issued patent will enhance Miralogix's inspection instrumentation, thus offering more features and value to our customers.
Source: www.medicalnewstoday.comEducation Seminars On Medicines - Publication Of Details By Medicines Australia Medicines Australia (MA) has posted on its website the details of all education events provided or sponsored for
healthcare practitioners by MA member companies. The ACCC has said that the publication of company events is the best way to bring greater public accountability for these events.
Source: www.medicalnewstoday.comPhoenix Marketing Study Demonstrates Impact Of Press Coverage And Advertising On Cholesterol Drug Users And Medication Brands A burst of unfavorable or confusing publicity often prompts users of
prescription medications to take swift actions that can hurt those medications' brand perception and market share, according to researchers at Phoenix
Healthcare, a Phoenix Marketing International practice.
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 PM
